Overview
Basic information about this protein and its source genome.
- Accession
- PA5365
- Gene
- PA5365 phoU
- Status
- annotated
- Amino acids
- 242
- Structure source
- Experimental + AlphaFold
Target profile
Computed evidence for target prioritization.
- Human off-target
- No hit
- Gut microbiome off-target
- hit
- Essential (DEG)
- Y
- Localization
- Cytoplasmic
Selected Druggability evidence
Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
Functional Annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Gene Ontology (GO)
9- GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
- GO:0042803 Binding to an identical protein to form a homodimer.
- GO:0060326 The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
- GO:0030643 A homeostatic process involved in the maintenance of a steady state level of phosphate ions within a cell.
- GO:0050922 Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
- GO:0045936 Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving phosphates.
- GO:2000186 Any process that stops, prevents, or reduces the frequency, rate or extent of phosphate transmembrane transport.
- GO:0050928 Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
- GO:0006817 The directed movement of phosphate ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Sequence Features
Domain/signature hits from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 122 | 234 | FunFam | G3DSA:1.20.58.220:FF:000001 | Phosphate-specific transport system accessory protein PhoU |
| 1 | 121 | Gene3D | G3DSA:1.20.58.220 | Phosphate transport system protein phou homolog 2; domain 2 |
| 1 | 121 | InterPro | IPR038078 | PhoU-like domain superfamily |
| 2 | 120 | FunFam | G3DSA:1.20.58.220:FF:000002 | Phosphate-specific transport system accessory protein PhoU |
| 8 | 229 | PIRSF | PIRSF003107 | PhoU |
| 8 | 229 | InterPro | IPR028366 | Phosphate transport system protein PhoU |
| 122 | 234 | Gene3D | G3DSA:1.20.58.220 | Phosphate transport system protein phou homolog 2; domain 2 |
| 122 | 234 | InterPro | IPR038078 | PhoU-like domain superfamily |
| 131 | 215 | Pfam | PF01895 | PhoU domain |
| 131 | 215 | InterPro | IPR026022 | PhoU domain |
| 27 | 113 | Pfam | PF01895 | PhoU domain |
| 27 | 113 | InterPro | IPR026022 | PhoU domain |
| 55 | 75 | Coils | Coil | Coil |
| 6 | 226 | PANTHER | PTHR42930 | PHOSPHATE-SPECIFIC TRANSPORT SYSTEM ACCESSORY PROTEIN PHOU |
| 6 | 226 | InterPro | IPR028366 | Phosphate transport system protein PhoU |
| 13 | 234 | SUPERFAMILY | SSF109755 | PhoU-like |
| 13 | 224 | NCBIfam | TIGR02135 | phosphate signaling complex protein PhoU |
| 13 | 224 | InterPro | IPR028366 | Phosphate transport system protein PhoU |
3D Structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.
Loading 3D structure...
Structural evidence
1 + 1Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 2 | 0.943 | ||||||
| 4 | 0.295 |
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 1 | 0.534 | ||||||
| 2 | 0.247 |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| PO3 | Q9X256 | 79.0 Da LogP -1.64 TPSA 63.2 | ✓ Ro5 | ✓ Clean |
[O-][P-](=O)[O-]
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
No virtual-screening candidates for this protein.
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.